Company: IOBT
Filing Date: 2025-03-04
Form Type: 8-K
Source: 0001193125-25-045673
Chunk: 1

Company: IO Biotech, Inc.
Filing Date: 2025-03-04
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01.      Regulation FD Disclosure.  

On March 4, 2025, the Company issued a press release providing business updates (the “ Press Release”). The Press Release primarily includes updates on the Company’s ongoing and planned clinical trials and disclosures regarding the Company’s cash and cash equivalents as of December 31, 2024.

A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 7.01 of this Current Report on Form8-K.

The information contained in this Current Report on Form8-Kis being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.